EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes
- PMID: 15284024
- DOI: 10.1152/ajpgi.00253.2004
EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes
Abstract
The epidermal growth factor receptor (EGFR) activates several signaling cascades in response to epidermal growth factor stimulation. One of these signaling events involves tyrosine phosphorylation of signal transducer and activator of transcription (STAT), whereas another involves activation of the phosphatidylinositol 3-OH kinase pathway. Two possibilities for STAT activation exist: a janus kinase (JAK)-dependent and a JAK-independent mechanism. Herein, we demonstrate that EGFR overexpression in primary esophageal keratinocytes activates STAT in a JAK-dependent fashion with the functional consequence of enhanced cell migration, which can be abolished by use of a JAK-specific inhibitor, AG-490. We determined the mechanisms underlying the signal transduction pathway responsible for increased cell migration. Stimulation of EGFR induces Tyr701 phosphorylation of STAT1 and initiates complex formation of STAT1 and STAT3 with JAK1 and JAK2. Thereafter, the STATs translocate to the nucleus within 15 min. In addition, we found that activation of this signaling pathway results in matrix metalloproteinase-1 (MMP-1) activity. By contrast, Akt activation does not impact the EGFR-STATs-JAKs complex formation and nuclear translocation of the STATs with subsequent MMP-1 activity, although Akt activation may contribute to cell migration through an independent mechanism. Taken together, we find that the recruitment of the STAT-JAK complex by EGFR is responsible for keratinocyte migration that, in turn, might be mediated by MMP-1 activation.
Similar articles
-
Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells.Biochem J. 1999 Aug 15;342 ( Pt 1)(Pt 1):231-8. Biochem J. 1999. PMID: 10432321 Free PMC article.
-
Concomitant inactivation of the epidermal growth factor receptor, phosphatidylinositol 3-kinase/Akt and Janus tyrosine kinase 2/signal transducer and activator of transcription 3 signalling pathways in cardiotoxin III-treated A549 cells.Clin Exp Pharmacol Physiol. 2010 Aug;37(8):833-40. doi: 10.1111/j.1440-1681.2010.05397.x. Epub 2010 Apr 26. Clin Exp Pharmacol Physiol. 2010. PMID: 20456425
-
JAK and STAT proteins are expressed and activated by IFN-gamma in rat pancreatic acinar cells.J Cell Physiol. 2005 Apr;203(1):209-16. doi: 10.1002/jcp.20216. J Cell Physiol. 2005. PMID: 15493010
-
IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled.Oncogene. 2000 May 15;19(21):2532-47. doi: 10.1038/sj.onc.1203594. Oncogene. 2000. PMID: 10851052 Review.
-
JAK/STAT-dependent gene regulation by cytokines.Drug News Perspect. 2005 May;18(4):243-9. doi: 10.1358/dnp.2005.18.4.908658. Drug News Perspect. 2005. PMID: 16034480 Review.
Cited by
-
The EGF/EGFR axis and its downstream signaling pathways regulate the motility and proliferation of cultured oral keratinocytes.FEBS Open Bio. 2023 Aug;13(8):1469-1484. doi: 10.1002/2211-5463.13653. Epub 2023 Jun 4. FEBS Open Bio. 2023. PMID: 37243482 Free PMC article.
-
The Invasion Factor ODZ1 Is Upregulated through an Epidermal Growth Factor Receptor-Induced Pathway in Primary Glioblastoma Cells.Cells. 2024 Apr 30;13(9):766. doi: 10.3390/cells13090766. Cells. 2024. PMID: 38727302 Free PMC article.
-
DAMPs Drive Fibroinflammatory Changes in the Glaucomatous ONH.Invest Ophthalmol Vis Sci. 2024 Oct 1;65(12):13. doi: 10.1167/iovs.65.12.13. Invest Ophthalmol Vis Sci. 2024. PMID: 39382882 Free PMC article.
-
Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer.Front Pharmacol. 2021 Nov 15;12:772510. doi: 10.3389/fphar.2021.772510. eCollection 2021. Front Pharmacol. 2021. PMID: 34867402 Free PMC article. Review.
-
Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agents.Cancer Res. 2009 Oct 1;69(19):7612-8. doi: 10.1158/0008-5472.CAN-09-1823. Epub 2009 Sep 14. Cancer Res. 2009. PMID: 19752087 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous